Search Results - "Dixon, Matthew E.B."

Endoscopic hemostatic spray for uncontrolled bleeding after complicated endoscopic mucosal resection or endoscopic submucosal dissection: a report of 2 cases by Hartz, Kayla M., Lee, Roland Y., Walsh, Leonard T., Dixon, Matthew E.B., Moyer, Matthew T.

“…There is a significant bleeding risk after gastric endoscopic submucosal dissection (ESD) and EMR cases. This case series describes the use of an endoscopic…”
Get full text

High-risk main-duct intraductal papillary mucinous neoplasm successfully treated with EUS-guided chemoablation by Hartz, Kayla M., Dixon, Matthew E.B., Levenick, John, Moyer, Matthew T.

Get full text

Undertreatment of Pancreatic Cancer by Torres, Madeline B., Dixon, Matthew E.B., Gusani, Niraj J.

“…Pancreatic cancer is the third leading cause of cancer deaths in the United States. Black patients with pancreatic cancer experience higher incidence and…”
Get full text

Utilization of Multiorgan Radiomics to Predict Future Liver Remnant Hypertrophy After Portal Vein Embolization: Another Tool for the Toolbox? by Dixon, Matthew E. B., Pappas, Sam G.

Get full text

Management of Clinical T2N0 Lower Esophageal and Gastroesophageal Junction Adenocarcinoma: What Is the Optimal Treatment? by Perez Holguin, Rolfy A., Olecki, Elizabeth J., Stahl, Kelly A., Wong, William G., Dixon, Matthew E.B., Peng, June S.

Get full text

Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial by D’Angelica, Michael I, Ellis, Ryan J, Liu, Jason B, Brajcich, Brian C, Gönen, Mithat, Thompson, Vanessa M, Cohen, Mark E, Seo, Susan K, Zabor, Emily C, Babicky, Michele L, Bentrem, David J, Behrman, Stephen W, Bertens, Kimberly A, Celinski, Scott A, Chan, Carlos H. F, Dillhoff, Mary, Dixon, Matthew E. B, Fernandez-del Castillo, Carlos, Gholami, Sepideh, House, Michael G, Karanicolas, Paul J, Lavu, Harish, Maithel, Shishir K, McAuliffe, John C, Ott, Mark J, Reames, Bradley N, Sanford, Dominic E, Sarpel, Umut, Scaife, Courtney L, Serrano, Pablo E, Smith, Travis, Snyder, Rebecca A, Talamonti, Mark S, Weber, Sharon M, Yopp, Adam C, Pitt, Henry A, Ko, Clifford Y

“…IMPORTANCE: Despite improvements in perioperative mortality, the incidence of postoperative surgical site infection (SSI) remains high after…”
Get full text

Bilobar Colorectal Liver Metastases: Challenges and Opportunities by Dixon, Matthew E. B., Gusani, Niraj J.

Get full text

Prediction of post-hepatectomy liver failure by preoperative gadoxetate disodium-enhanced magnetic resonance imaging by Lauscher, Johannes C., Dixon, Matthew E.B., Jada, George, Afshin, Mariam, Neumann, Konrad, Cheung, Helen, Martel, Guillaume, Hallet, Julie, Coburn, Natalie, Law, Calvin, Milot, Laurent, Karanicolas, Paul J.

“…Approximately 15% of patients experience post-hepatectomy liver failure after major hepatectomy. Poor hepatocyte uptake of gadoxetate disodium, a magnetic…”
Get full text

Disparities in Surgical Treatment of Resectable Pancreatic Adenocarcinoma at Minority Serving Hospitals by Olecki, Elizabeth J., Perez Holguin, Rolfy A., Mayhew, Mackenzie M., Wong, William G., Vining, Charles C., Peng, June S., Shen, Chan, Dixon, Matthew E.B.

“…Minority serving hospitals (MSH) are those serving a disproportionally high number of minority patients. Previous research has demonstrated that treatment at…”
Get full text

Undertreatment of Pancreatic Cancer: The Intersection of Bias, Biology, and Geography by Torres, Madeline B, Dixon, Matthew E B, Gusani, Niraj J

“…Pancreatic cancer is the third leading cause of cancer deaths in the United States. Black patients with pancreatic cancer experience higher incidence and…”
Get full text

Management of Clinical T2N0 Esophageal and Gastroesophageal Junction Adenocarcinoma: What Is the Optimal Treatment? by Perez Holguin, Rolfy A., Olecki, Elizabeth J., Stahl, Kelly A., Wong, William G., Vining, Charles C., Dixon, Matthew E. B., Peng, June S.

“…Background The current standard of care for locally advanced esophageal and gastroesophageal junction (GEJ) adenocarcinoma includes neoadjuvant chemoradiation…”
Get full text

Comparison of epidural infusion versus intrathecal morphine block as part of enhanced recovery after open pancreatoduodenectomy by El‐Mallah, Jessica C., Greene, Alicia C., Clegg, Taylor J., Shah, Sejal J., El‐Mallah, Saif N., Vining, Charles C., Dixon, Matthew E. B., Peng, June S.

“…Background and Objectives The accepted approach to pain management following open pancreatoduodenectomy (PD) remains controversial, with the most recent…”
Get full text

Pathologic upstaging in resected pancreatic adenocarcinoma: Risk factors and impact on survival by Olecki, Elizabeth J., Stahl, Kelly A., Torres, Madeline B., Peng, June S., Shen, Chan, Dixon, Matthew E.B., Gusani, Niraj J.

“…Background Clinical and pathologic staging determine treatment of pancreatic cancer. Clinical stage has been shown to underestimate final pathologic stage in…”
Get full text

Is preoperative biliary stenting associated with increased rate of postoperative complications for patients undergoing pancreatoduodenectomy? A review of national surgical quality improvement program data by Olecki, Elizabeth J., Swinarska, Joanna, Perez Holguin, Rolfy A., Stahl, Kelly A., Wong, William G., Peng, June S., Dixon, Matthew E.B.

“…Jaundice in the setting of periampullary neoplasms is often treated with biliary stenting. Level 1 data demonstrated an increase in perioperative complications…”
Get full text